The Utility of a Diagnostic Scoring System for Disseminated Intravascular Coagulation

Critical Care Clinics

Volumn 28, Issue 3, 2012, Pages 373-388

  Gando, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Critical illness; Diagnosis; Disseminated intravascular coagulation; Score

Indexed keywords

BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; MOLECULAR MARKER; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ANTICOAGULATION; BLOOD CLOTTING; DIAGNOSTIC ACCURACY; DIAGNOSTIC SCORING SYSTEM; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; REVIEW; SCORING SYSTEM; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOPLASTIN TIME;

BIOLOGICAL MARKERS; CRITICAL CARE; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; NEEDS ASSESSMENT; PLATELET COUNT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84862514973     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2012.04.004     Document Type: Review

References (69)

1. Colman R.W., Robby S.J., Minna J.D. Disseminated intravascular coagulation (DIC): an approach. Am J Med 1972, 52:679-689.
2. Spero J.A., Lewis J.H., Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 1980, 43:28-33.
3. Kobayashi N., Maekawa T., Takada M., et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1983, 49:265-275.
4. Wada H., Gabazza E.C., Asakura H., et al. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Haemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003, 74:17-22.
5. Taylor F.B., Toh C.H., Hoots W.K., et al. Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330.
6. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee.
7. Esmon C.T., Fukudome K., Mather T., et al. Inflammation, sepsis, and coagulation. Haematologica 1999, 84:254-259.
8. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123.
9. Levi M., ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592.
10. Gando S., Iba T., Eguchi Y., et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006, 34:625-631.
11. Gando S., Saitoh D., Ogura H., et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008, 36:145-150.
12. Bakhtiari K., Meijers J.C., de Jong E., et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004, 32:2416-2421.
13. Toh C.H., Hoots W.K. The scoring system of the Scientific and Standardization Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 2007, 5:604-606. SSC on disseminated intravascular coagulation of the ISTH.
14. Dempfle C.E. Comparing DIC scores: not an easy task indeed. Thromb Res 2009, 124:651-652.
15. Takemitsu T., Wada H., Hatada T., et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost 2011, 105:40-44.
16. Levi M., Toh C.H., Thachil J., et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009, 145:24-33.
17. Wada H., Asakura H., Okamoto K., et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 2010, 125:6-11.
18. Di Nisio M., Baudo F., Cosmi B., et al. Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2012, 129(5). e177-e84.
19. Iba T., Asakura H. Comparison between British and Japanese guidelines for the diagnosis and treatment of disseminated intravascular coagulation. Br J Haematol 2010, 149:461-462.
20. Levi M. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?. Thromb Res 2010, 125:4-5.
21. Gando S. The SISET incorrectly cited the JAAM DIC scoring system. Thromb Res 2012, 129:660.
22. Dinarello C.A., Gelfand J.A., Wolff S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993, 269:1829-1835.
23. Nasraway S.A. Sepsis research: we must change the course. Crit Care Med 1999, 27:427-430.
24. Levi M., de Jonge E., van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004, 36:41-49.
25. Gando S., Kameue T., Nanzaki S., et al. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996, 75:224-228.
26. Siegel T., Seligsohn U., Aghai E., et al. Clinical and laboratory aspects of disseminated intravascular coagulation: a study of 118 cases. Thromb Haemost 1978, 39:122-134.
27. Dhainaut J.F., Shorr A.F., Macias W.L., et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005, 33:341-348.
28. Dhainaut J.F., Yan S.B., Joyce D.E., et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004, 2:1924-1933.
29. Kienast J., Juers M., Wiedermann C.J., et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006, 4:90-97.
30. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38(Suppl):S35-S42.
31. Saito H., Maruyama I., Shimazaki S., et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007, 5:31-41.
32. Wada H., Wakita Y., Nakase T., et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment begun. Thromb Haemost 1995, 74:848-852.
33. Favaloro E.J. Laboratory testing in disseminated intravascular coagulation. Seimin Thromb Haemost 2010, 36:458-467.
34. Levi M. DIC: which laboratory tests are most useful. Blood Rev 2011, 25:33-37.
35. ten Cate H. Thrombocytopenia: one of the markers of disseminated intravascular coagulation. Pathophysiol Haemost Thromb 2003, 33:413-416.
36. Drews R.E., Weinberger S.E. Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000, 162:347-351.
37. Kitchen S., Preston F.E. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy. Semin Thromb Hemost 1999, 25:17-25.
38. Kim H.K., Hong K.H., Toh C.H. Application of the international normalized ratio in the scoring system for disseminated intravascular coagulation. J Thromb Haemost 2010, 8:1116-1118. Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis.
39. Yu M., Nardella A., Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med 2000, 28:1777-1780.
40. Franchini M., Di Minno M.N., Coppola A. Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost 2010, 36:388-403.
41. Asakura H., Ontachi Y., Mizutani T., et al. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med 2001, 29:1164-1168.
42. Madoiwa S., Nunomiya S., Ono T., et al. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation. Int J Hematol 2006, 84:398-405.
43. Bick R.L. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 2002, 8:1-31.
44. Wada H., Gabazza E., Nakasaki T., et al. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. Semin Thromb Hemost 2000, 26:17-21.
45. Asakura H., Wada H., Okamoto K., et al. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections. Thromb Haemost 2006, 95:282-287.
46. Kawasugi K., Wada H., Hatada T., et al. Prospective evaluation of haemostatic abnormalities in overt DIC due to various underlying diseases. Thromb Res 2011, 128:186-190.
47. Taylor F.B., Kinasewiz G.T. The diagnosis and management of disseminated intravascular coagulation. Current Hematol Rep 2002, 1:34-40.
48. Hoots W.K. Non-overt disseminated intravascular coagulation: definition and pathophysiological implications. Blood Rev 2002, 16(Suppl 1):S3-S9.
49. Gando S., Wada H., Asakura H., et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 2005, 11:71-76.
50. Gando S., Saitoh D., Ogura H., et al. Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis. Thromb Res 2009, 123:715-718.
51. Hayakawa M., Gando S., Hoshino H. A prospective comparison of new Japanese criteria versus ISTH criteria. Clin Appl Thromb Hemost 2007, 13:172-181.
52. Singh R.K., Baronia A.K., Sahoo J.N., et al. Prospective comparison of new Japanese Association for Acute Medicine (JAAM) DIC and International Society of Thrombosis and Haemostasis (ISTH) DIC score in critically ill septic patients. Thromb Res 2012, 129(4):e119-e125.
53. Iwai K., Uchino S., Endo A., et al. Prospective external validation of the new scoring system for disseminated intravascular coagulation by Japanese Association for Acute Medicine (JAAM). Thromb Res 2010, 126:217-221.
54. Sivula M., Tallgren M., Pettilä V. Modified scorer for disseminated intravascular coagulation in the critically ill. Intensive Care Med 2005, 31:1209-1214.
55. Volves C., Wuillemin W.A., Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagl Fibrinolysis 2006, 17:445-451.
56. Cauchie P.H., Cauchie C.H., Boudjeltia K.Z., et al. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital - meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. Am J Hematol 2006, 81:414-419.
57. Angstwurm M.W., Dempfle C.E., Spannagl M. New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 2006, 34:314-320.
58. Khemani R.G., Bart R.D., Alonzo T.A., et al. Disseminated intravascular coagulation score is associated with mortality for children with shock. Intensive Care Med 2009, 35:327-333.
59. Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol 2009, 22:129-136.
60. Thachil J., Toh C.H. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009, 23:167-176.
61. Dempfle C.E., Wurst M., Smolinski M., et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC core. Thromb Haemost 2004, 91:812-818.
62. Toh C.H., Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identify non-overt disseminated intravascular coagulation. Blood Coagl Fibrinolysis 2005, 16:69-74.
63. Egi M., Morimatsu H., Wiedermann C.J., et al. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels. Thromb Haemost 2009, 101:696-705.
64. Wada H., Hatada T., Okamoto K., et al. Modified non-overt DIC diagnostic criteria predict the early phase of overt DIC. Am J Hematol 2010, 85:691-694.
65. Sawamura A., Hayakawa M., Gando S., et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009, 124:608-613.
66. Sawamura A., Hayakawa M., Gando S., et al. Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria for patients at an early phase of trauma. Thromb Res 2009, 124:706-710.
67. Kobayashi T., Terao T., Maki M., et al. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 2001, 27:161-167.
68. Henzan N., Gando S., Uegaki S., et al. Diagnosis of obstetrical disseminated intravascular coagulation (DIC) using newly developed DIC diagnostic criteria for critically ill patients. JJAAM 2007, 18:793-802.
69. Yanada M., Matsushihta T., Suzuki M., et al. Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation. Eur J Haematol 2006, 77:282-287.